Health Policy Council

Launched in April 2020, the Health Policy Council is composed of a diverse cross-section of our members who come together to exchange ideas, inform OCC priorities, and provide government with timely recommendations.

Although the Council was in development prior to the COVID-19 crisis, now more than ever, the participating members’ direction will be critical to support the health care system today and lead recovery tomorrow.

Founding members of the Council include:

• Abbott Laboratories
• AbbVie
• Accerta
• Alzheimer Society of Ontario
• Amgen
• AstraZeneca
• BD
• Biogen
• BioMarin
• Boehringer Ingelheim
• Canada Health Infoway
• Dynacare
• Eli Lilly
• Goodlife Fitness
• Green Shield Canada
• GSK
• IMC
• Ingersoll Nurse Practitioner Led Clinic
• Janssen/J&J
• LifeLabs
• Medavie
• Medicago
• Medtronic
• Merck
• Northeastern University – Toronto
• Novartis Pharmaceuticals Canada Inc.
• Ontario Genomics
• Ontario Medical Association
• Roche
• Staffy
• Sun Life
• Takeda Canada
• Trudell Medical
• York University

Click here to learn more about the OCC’s ongoing advocacy work.

Click here to learn more about the OCC’s COVID-19 related advocacy.

For more information on how to join the Council, please contact, Sara Fegelman, Senior Policy Analyst